HomeBAX • NYSE
add
Baxter International Inc
Previous close
$35.70
Day range
$35.82 - $36.49
Year range
$32.28 - $44.01
Market cap
18.30B USD
Avg Volume
3.31M
P/E ratio
7.37
Dividend yield
3.23%
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 3.81B | 2.83% |
Operating expense | 1.09B | 3.71% |
Net income | -314.00M | -122.70% |
Net profit margin | -8.24 | -116.84% |
Earnings per share | 0.68 | 23.64% |
EBITDA | 653.00M | -0.76% |
Effective tax rate | -21.01% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.10B | 21.66% |
Total assets | 26.31B | -5.64% |
Total liabilities | 18.60B | -16.40% |
Total equity | 7.71B | — |
Shares outstanding | 510.18M | — |
Price to book | 2.38 | — |
Return on assets | 3.37% | — |
Return on capital | 4.20% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -314.00M | -122.70% |
Cash from operations | 115.00M | -67.24% |
Cash from investing | -91.00M | 47.40% |
Cash from financing | -936.00M | -680.00% |
Net change in cash | -934.00M | -2,006.12% |
Free cash flow | 155.00M | -27.19% |
About
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.
The company primarily focuses on products to treat kidney disease, and other chronic and acute medical conditions. The company had 2017 sales of $10.6 billion, across two businesses: BioScience and Medical Products. Baxter's BioScience business produces recombinant and blood plasma proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies and other chronic and acute blood-related conditions; products for regenerative medicine, and vaccines. Baxter's Medical Products business produces intravenous products and other products used in the delivery of fluids and drugs to patients; inhalational anaesthetics; contract manufacturing services; and products to treat end-stage kidney disease, or irreversible kidney failure, including products for peritoneal dialysis and hemodialysis. Wikipedia
Founded
1931
Headquarters
Website
Employees
60,000
